In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Cross Country Healthcares, Inc (NASDAQ: CCRN) was $8.03 for the day, up 0.37% from the previous closing price of $8.0. In other words, the price has increased by $0.37 from its previous closing price. On the day, 0.59 million shares were traded. CCRN stock price reached its highest trading level at $8.1575 during the session, while it also had its lowest trading level at $7.93.
Ratios:
Our analysis of CCRN’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.65 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.76. For the most recent quarter (mrq), Quick Ratio is recorded 3.45 and its Current Ratio is at 3.45. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 09 ’25 when CASH W LARRY bought 5,000 shares for $8.17 per share. The transaction valued at 40,829 led to the insider holds 204,632 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CCRN now has a Market Capitalization of 263062400 and an Enterprise Value of 166134416. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.23 while its Price-to-Book (P/B) ratio in mrq is 0.64. Its current Enterprise Value per Revenue stands at 0.147 whereas that against EBITDA is 7.938.
Stock Price History:
The Beta on a monthly basis for CCRN is 0.48, which has changed by -0.5533222 over the last 52 weeks, in comparison to a change of 0.13329959 over the same period for the S&P500. Over the past 52 weeks, CCRN has reached a high of $18.30, while it has fallen to a 52-week low of $7.43. The 50-Day Moving Average of the stock is -27.70%, while the 200-Day Moving Average is calculated to be -38.41%.
Shares Statistics:
CCRN traded an average of 707.21K shares per day over the past three months and 2448790 shares per day over the past ten days. A total of 32.52M shares are outstanding, with a floating share count of 30.99M. Insiders hold about 5.41% of the company’s shares, while institutions hold 102.14% stake in the company. Shares short for CCRN as of 1764288000 were 3264651 with a Short Ratio of 4.62, compared to 1761868800 on 2493687. Therefore, it implies a Short% of Shares Outstanding of 3264651 and a Short% of Float of 10.040000000000001.
Earnings Estimates
. The current rating of Cross Country Healthcares, Inc (CCRN) reflects the combined expertise of 7.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $0.01, with high estimates of $0.03 and low estimates of $0.0.
Analysts are recommending an EPS of between $0.13 and $0.02 for the fiscal current year, implying an average EPS of $0.09. EPS for the following year is $0.1, with 7.0 analysts recommending between $0.32 and -$0.04.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 8 analysts. It ranges from a high estimate of $263.06M to a low estimate of $246.71M. As of. The current estimate, Cross Country Healthcares, Inc’s year-ago sales were $309.94MFor the next quarter, 8 analysts are estimating revenue of $256.69M. There is a high estimate of $277.1M for the next quarter, whereas the lowest estimate is $243.57M.
A total of 8 analysts have provided revenue estimates for CCRN’s current fiscal year. The highest revenue estimate was $1.08B, while the lowest revenue estimate was $1.06B, resulting in an average revenue estimate of $1.07B. In the same quarter a year ago, actual revenue was $1.34BBased on 8 analysts’ estimates, the company’s revenue will be $1.01B in the next fiscal year. The high estimate is $1.07B and the low estimate is $984.7M.
